Meeting NewsVideo

VIDEO: Bimatoprost SR shows continued IOP lowering at 1 year

SAN FRANCISCO — At the American Academy of Ophthalmology annual meeting, E. Randy Craven, MD, discusses a study showing the long-term IOP-lowering effect of the Bimatoprost SR implant from Allergan.

SAN FRANCISCO — At the American Academy of Ophthalmology annual meeting, E. Randy Craven, MD, discusses a study showing the long-term IOP-lowering effect of the Bimatoprost SR implant from Allergan.

    See more from American Academy of Ophthalmology Meeting